Josette Ragheb
Apple Valley, CANPI 1982849923
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $570,079 of the $570,379 with a category attached, or 99.9%. Alkermes, Inc. accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $374,169 and has fallen 51.1% since, to $182,921 in 2023.
Across 31 payments — averaging $18,399 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$570K
- Agilent Technologies, Inc.$300
Across 111 payments — averaging $15,603 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ventana Medical Systems, Inc.$1.4M
- GSK$355K
What the payments were for
- Consulting fees$570,079100%
- Travel & lodging$1460%
- Food & beverage$1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 26 | $570,079 |
| Agilent Technologies, Inc. | 5 | $300 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PD-L1 IHC 22C3$146
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.